Table 2 Outcomes
Variables | CLBP group (n = 30) | Healthy control group (n = 30) | ||
BPA wider | 18 (60%) | 16 (53%) | ||
BPA narrower | 8 (26.5%) | 10 (33.5%) | ||
BPA original | 4 (13.5%) | 4 (13.5%) | ||
Variables | Median | Range | Median | Range |
BPA deviation steps (0–4) | 2.0 (IQR 2.0) | 0.0–4.0 | 2.0 (IQR 2.0) | 0.0–4.0 |
TPD horizontal right (mm) | 65.0 (IQR 33.8) | 15.0–105.0 | 67.5 (IQR 23.8) | 30.0–105.0 |
TPD horizontal left (mm) | 67.5 (IQR 30.0) | 30.0–120.0 | 57.5 (IQR 18.8) | 25.0–140.0 |
TPD vertical right (mm) | 45.0 (IQR 20.0) | 20.0–110.0 | 35.0 (IQR 33.8) | 15.0–85.0 |
TPD vertical left (mm) | 42.5 (IQR 20.0) | 15.0–150.0 | 35.0 (IQR 28.8) | 10.0–90.0 |
MCT positive (0–6) | 3.0 (IQR 2.0) | 1.0–5.0 | 2.0 (IQR 1.0) | 0.0–5.0 |
FABQ (0–96) | 33 (IQR 28.8) | 0–96 | 1 (IQR 6.8) | 0–37 |
HADS (0–42) | 9 (IQR 5.5) | 0–17 | 3.5 (IQR 5.8) | 0–16 |
FreBaQ (0–36) | 7 (IQR 6.8) | 0–22 | 0 (IQR 2.0) | 0–8 |